Quick Takeaways
- Mark Bodmer has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $8,492.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Mark Bodmer
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Mark Bodmer is at least $8,492 dollars as of 08 Nov 2023. Mark Bodmer is the CSO, President of R&D of Evelo Biosciences, Inc. and owns shares of Evelo Biosciences, Inc. stock worth about $8.5K.
- Signature
- /s/ Marella Thorell, Attorney-in-Fact for Mark Bodmer
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Mark Bodmer and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Evelo Biosciences, Inc. ($8,492).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Mark Bodmer
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| EVLO | Evelo Biosciences, Inc. | CSO, President of R&D | $8,492 | 07 Nov 2023 |
Insider Transactions Reported by Mark Bodmer:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.